KalVista Pharmaceuticals, Inc. Insider Transactions
KalVista Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 7,294 @ $16.51 | $120.42 K | 424,520 | 12/08/2025 | 12/09/2025 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 5,296 @ $13.45 | $71.24 K | 131,831 | 11/24/2025 | 11/26/2025 | |
|
Piekos Brian
CFO |
Sell | 4,471 @ $13.45 | $60.14 K | 10,529 | 11/24/2025 | 11/26/2025 | |
|
Sweeny Nicole
Chief Commercial Officer |
Sell | 3,813 @ $13.45 | $51.29 K | 39,728 | 11/24/2025 | 12/04/2025 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 10,940 @ $13.45 | $147.15 K | 416,189 | 11/24/2025 | 11/26/2025 | |
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 4,331 @ $13.45 | $58.26 K | 223,508 | 11/24/2025 | 11/26/2025 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 3,075 @ $14.48 | $44.52 K | 125,877 | 11/18/2025 | 11/19/2025 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 4,466 @ $14.48 | $64.67 K | 403,879 | 11/18/2025 | 11/19/2025 | |
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 2,683 @ $14.48 | $38.85 K | 133,574 | 11/18/2025 | 11/19/2025 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 3,328 @ $11.55 | $38.44 K | 398,981 | 11/12/2025 | 11/13/2025 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 7,294 @ $15.84 | $115.54 K | 395,189 | 09/08/2025 | 09/09/2025 | |
|
Sweeny Nicole
Chief Commercial Officer |
Sell | 1,480 @ $13.42 | $19.86 K | 32,291 | 08/25/2025 | 08/26/2025 | |
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 1,954 @ $13.42 | $26.22 K | 132,052 | 08/25/2025 | 08/26/2025 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 2,336 @ $13.42 | $31.35 K | 122,505 | 08/25/2025 | 08/26/2025 | |
|
Sweeny Nicole
Chief Commercial Officer |
Sell | 1,864 @ $13.22 | $24.65 K | 28,771 | 08/22/2025 | 08/25/2025 | |
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 2,362 @ $13.22 | $31.23 K | 130,881 | 08/22/2025 | 08/25/2025 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 10,940 @ $13.22 | $144.66 K | 386,858 | 08/22/2025 | 08/25/2025 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 2,942 @ $13.22 | $38.90 K | 119,841 | 08/22/2025 | 08/25/2025 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 2,939 @ $13.19 | $38.76 K | 116,533 | 08/18/2025 | 08/19/2025 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 4,409 @ $13.19 | $58.14 K | 374,548 | 08/18/2025 | 08/19/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
KalVista Pharmaceuticals, Inc. FAQ's
The list of insiders at KalVista Pharmaceuticals, Inc. includes Venrock Healthcare Capital Partners III, L.P., Yea Christopher, Audhya Paul K., Palleiko Benjamin L, Sweeny Nicole, Piekos Brian.
Insiders have sold a total of 211.34 K KalVista Pharmaceuticals, Inc. shares in the last 12 months for a total of 2.92 M sold.
The following insiders have sold KalVista Pharmaceuticals, Inc. shares in the last 12 months: Yea Christopher ($789.05 K), Audhya Paul K. ($368.54 K), Palleiko Benjamin L ($1.60 M), Sweeny Nicole ($95.80 K), Piekos Brian ($60.14 K),
Insiders have purchased a total of 317.51 K KalVista Pharmaceuticals, Inc. shares in the last 12 months for a total of 2.94 M.
The following insiders have purchased KalVista Pharmaceuticals, Inc. shares in the last 12 months: Venrock Healthcare Capital Partners III, L.P. ($2.94 M),